Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.4/5
Sosei Group

Sosei Group (4565 JP)

34
Analysis
Health CareJapan
Sosei Group Corporation is a holding company which was established through reorganization. The Group companies are biopharmaceutical companies specializing in drug development. Sosei Group enters into license agreements primarily with US, EU, and Japanese companies to market the licensed drugs in Japan and find alternative usage on such drugs.
more
bullishSosei Group
02 May 2025 12:00Issuer-paid

Sosei Group (4565 JP): Q1 FY12/25 flash update

Revenue increased 44.1% YoY to JPY6.6bn, driven by Quviviq® revenue and milestone payments in Q1 FY12/25. R&D expenses rose 20.4% YoY to...

Logo
228 Views
Share
06 Jul 2025 00:30

APAC Healthcare Weekly (July 6)- Shionogi, Simcere, Wuxi XDC, Sino Bio, Apollo Hosp, Torrent Pharma

Simcere, CSPC, and Sino Bio got approvals for their new drugs in China. Apollo Hospital announced a demerger. Torrent is acquiring controlling...

Logo
463 Views
Share
07 Dec 2024 23:30

APAC Healthcare Weekly (Dec 8)- Eoflow, Celltrion, Takeda, Medipal, SanBio, Aurobindo Pharma

The insight covers key developments in prominent APAC healthcare companies. These developments are expected to impact the financials of the...

Logo
531 Views
Share
bearishSosei Group
30 Jun 2023 07:47

Sosei Group (4565 JP): Hit Hard by Partner’s Clinical Trial Termination; Need Time to Recover

Pfizer decided to discontinue the development of lotiglipron, one of the candidates resulting from Pfizer’s drug discovery collaboration with...

Logo
516 Views
Share
bullishTencent
15 Apr 2023 23:05

Last Week in Event SPACE: Tencent, Ecopro, Japan’s Governance, Jardines, Citizen

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
466 Views
Share
x